GO Guangdong, Your Smart Gateway to Authentic Cantonese Culture This Spring Festival

GUANGZHOU, China, Feb. 13, 2026 /PRNewswire/ — As travel to China rebounds…

Global Times: A French girl living in Beijing's hutongs

BEIJING, Feb. 13, 2026 /PRNewswire/ — This year marks the 105th anniversary of…

Global Times: 'Sister Wu' sells vegetables by 'slow train'

BEIJING, Feb. 13, 2026 /PRNewswire/ — "Sister Wu, can live chickens be taken…

Dreame Singapore Debuts X60 Ultra: The Ultra-Slim AI-Powered Robot Vacuum With Blue Active Light

SINGAPORE, Feb. 13, 2026 /PRNewswire/ — Dreame Technology today announced the Singapore…

Track II Diplomacy in Action: Scholars Forge Pathways for Cambodia-Thailand Peace

BEIJING, Feb. 13, 2026 /PRNewswire/ — A release from China Report ASEAN: On…

Uluṟu's Global Art Icon 'Field of Light' Marks 10 Years with Public Celebrations

Bruce Munro’s original installation reaches 750,000 visitors as new art, guest experiences and…

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia

– Comprehensive review of recent milestones highlights statistically significant efficacy in prostate…

Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

SAN FRANCISCO and SUZHOU, China, Feb. 13, 2026 /PRNewswire/ — Innovent Biologics, Inc.…